Found: 52
Select item for more details and to access through your institution.
The impact of stroke and bleeding on mortality and quality of life during the first year after TAVI: A POPular TAVI subanalysis.
- Published in:
- Catheterization & Cardiovascular Interventions, 2024, v. 104, n. 5, p. 1107, doi. 10.1002/ccd.31218
- By:
- Publication type:
- Article
Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3249, doi. 10.3390/jcm9103249
- By:
- Publication type:
- Article
Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical Practice.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3173, doi. 10.3390/jcm9103173
- By:
- Publication type:
- Article
Prehospital tirofiban increases the rate of disrupted myocardial infarction in patients with ST-segment elevation myocardial infarction: insights from the On-TIME 2 trial.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2024, v. 13, n. 8, p. 595, doi. 10.1093/ehjacc/zuae074
- By:
- Publication type:
- Article
Reply to: "Paraoxonase-1 and clopidogrel efficacy".
- Published in:
- 2011
- By:
- Publication type:
- Letter
Corrigendum: Paraoxonase-1 is a major determinant of clopidogrel efficacy.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Paraoxonase-1 is a major determinant of clopidogrel efficacy.
- Published in:
- Nature Medicine, 2011, v. 17, n. 1, p. 110, doi. 10.1038/nm.2281
- By:
- Publication type:
- Article
Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial.
- Published in:
- Drugs, 2020, v. 80, n. 10, p. 995, doi. 10.1007/s40265-020-01323-x
- By:
- Publication type:
- Article
The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
- Published in:
- European Heart Journal, 2024, v. 45, n. 33, p. 3057, doi. 10.1093/eurheartj/ehae440
- By:
- Publication type:
- Article
The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment.
- Published in:
- European Heart Journal, 2024, v. 45, n. 19, p. 1727, doi. 10.1093/eurheartj/ehae123
- By:
- Publication type:
- Article
Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
- Published in:
- European Heart Journal, 2021, v. 42, n. 10, p. 1038, doi. 10.1093/eurheartj/ehaa1097
- By:
- Publication type:
- Article
Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience.
- Published in:
- Cardiology, 2017, v. 138, n. 3, p. 164, doi. 10.1159/000475705
- By:
- Publication type:
- Article
CT-Derived Patient-Specific Computer Simulation of the Novel Self-Expanding Evolut FX Implantation: A Case Series.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 20, p. 6212, doi. 10.3390/jcm13206212
- By:
- Publication type:
- Article
Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3992, doi. 10.3390/jcm10173992
- By:
- Publication type:
- Article
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case–control study.
- Published in:
- European Heart Journal, 2010, v. 31, n. 24, p. 3046, doi. 10.1093/eurheartj/ehq321
- By:
- Publication type:
- Article
A single dose of erythropoietin in ST-elevation myocardial infarction.
- Published in:
- European Heart Journal, 2010, v. 31, n. 21, p. 2593
- By:
- Publication type:
- Article
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel<sup>†</sup>.
- Published in:
- European Heart Journal, 2005, v. 26, n. 14, p. 1379, doi. 10.1093/eurheartj/ehi174
- By:
- Publication type:
- Article
Is there a place for heart-type fatty acid binding protein in the era of high-sensitive cardiac troponin T for the diagnosis of acute myocardial infarction? A systematic review.
- Published in:
- Emergency Care Journal, 2019, v. 15, n. 2, p. 51, doi. 10.4081/ecj.2019.8049
- By:
- Publication type:
- Article
2023 European Society of Cardiology guidelines for the management of acute coronary syndromes: Statement of endorsement by the NVVC.
- Published in:
- Netherlands Heart Journal, 2024, v. 32, n. 10, p. 338, doi. 10.1007/s12471-024-01896-2
- By:
- Publication type:
- Article
Reply to 'Revisiting postsurgical aortic pseudoaneurysm mortality and treatment options'.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis.
- Published in:
- Netherlands Heart Journal, 2023, v. 31, n. 12, p. 489, doi. 10.1007/s12471-023-01824-w
- By:
- Publication type:
- Article
Transcatheter closure of postsurgical aortic pseudoaneurysms guided by three-dimensional image reconstruction: a single-centre experience.
- Published in:
- Netherlands Heart Journal, 2023, v. 31, n. 10, p. 383, doi. 10.1007/s12471-023-01784-1
- By:
- Publication type:
- Article
A clinical risk score to identify patients at high risk of very late stent thrombosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High risk of stent thrombosis in the first 6 months after coronary stenting: Do not discontinue clopidogrel early after ACS.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Percutaneous Atrial Shunt Closure Using the Novel Occlutech Figulla Device: 6-Month Efficacy and Safety.
- Published in:
- Journal of Interventional Cardiology, 2011, v. 24, n. 3, p. 264, doi. 10.1111/j.1540-8183.2010.00619.x
- By:
- Publication type:
- Article
Double-Trouble: Three Cases with Simultaneous Stent Thrombosis in Different Coronary Arteries.
- Published in:
- Journal of Interventional Cardiology, 2007, v. 20, n. 2, p. 132, doi. 10.1111/j.1540-8183.2007.00240.x
- By:
- Publication type:
- Article
Cutting Balloon for In-Stent Restenosis:.
- Published in:
- Journal of Interventional Cardiology, 2004, v. 17, n. 4, p. 197, doi. 10.1111/j.1540-8183.2004.00378.x
- By:
- Publication type:
- Article
Stenting for Restenotic Lesions with the BARD XT Stent.
- Published in:
- Journal of Interventional Cardiology, 2003, v. 16, n. 3, p. 227, doi. 10.1034/j.1600-0854.2003.8050.x
- By:
- Publication type:
- Article
Tailored P2Y<sub>12</sub> inhibitor treatment in patients undergoing non-urgent PCI—the POPular Risk Score study.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 9, p. 1201, doi. 10.1007/s00228-019-02696-z
- By:
- Publication type:
- Article
Effect of aortic cross-clamp time on late survival after isolated aortic valve replacement.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2021, v. 32, n. 2, p. 222, doi. 10.1093/icvts/ivaa244
- By:
- Publication type:
- Article
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting
- Published in:
- Clinical Cardiology, 2016, v. 39, n. 10, p. 555, doi. 10.1002/clc.22572
- By:
- Publication type:
- Article
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 2, p. 165, doi. 10.1007/s40256-022-00565-2
- By:
- Publication type:
- Article
Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s).
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 24, p. 1, doi. 10.1161/JAHA.123.031855
- By:
- Publication type:
- Article
Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Diagnostic performance and clinical implications for enhancing a hybrid quantitative flow ratio–FFR revascularization decision-making strategy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85933-9
- By:
- Publication type:
- Article
The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2023, v. 28, p. 1, doi. 10.1177/10742484231210704
- By:
- Publication type:
- Article
High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia.
- Published in:
- Respirology, 2017, v. 22, n. 5, p. 1000, doi. 10.1111/resp.12996
- By:
- Publication type:
- Article
Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2023, v. 56, n. 4, p. 499, doi. 10.1007/s11239-023-02867-x
- By:
- Publication type:
- Article
Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y<sub>12</sub> inhibitors in ST‐segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
- Published in:
- Catheterization & Cardiovascular Interventions, 2022, v. 99, n. 3, p. 676, doi. 10.1002/ccd.29861
- By:
- Publication type:
- Article
Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathy
- Published in:
- Catheterization & Cardiovascular Interventions, 2021, v. 97, n. 3, p. 488, doi. 10.1002/ccd.29178
- By:
- Publication type:
- Article
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial.
- Published in:
- Catheterization & Cardiovascular Interventions, 2020, v. 96, n. 3, p. E377, doi. 10.1002/ccd.28642
- By:
- Publication type:
- Article
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial.
- Published in:
- Catheterization & Cardiovascular Interventions, 2019, v. 93, n. 7, p. 1374, doi. 10.1002/ccd.28295
- By:
- Publication type:
- Article
Pre‐hospital administration of ticagrelor in diabetic patients with ST‐elevation myocardial infarction undergoing primary angioplasty: A sub‐analysis of the ATLANTIC trial.
- Published in:
- Catheterization & Cardiovascular Interventions, 2019, v. 93, n. 7, p. E369, doi. 10.1002/ccd.27921
- By:
- Publication type:
- Article
Effect of alcohol dosage on long-term outcomes after alcohol septal ablation in patients with hypertrophic cardiomyopathy.
- Published in:
- Catheterization & Cardiovascular Interventions, 2016, v. 88, n. 6, p. 945, doi. 10.1002/ccd.26448
- By:
- Publication type:
- Article
Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial.
- Published in:
- Clinical Research in Cardiology, 2021, v. 110, n. 5, p. 649, doi. 10.1007/s00392-020-01787-7
- By:
- Publication type:
- Article
Haemodynamic effects of patent foramen ovale and atrial septal defect closure: a comparison during percutaneous shunt closure.
- Published in:
- Clinical Physiology & Functional Imaging, 2010, v. 30, n. 1, p. 64, doi. 10.1111/j.1475-097X.2009.00905.x
- By:
- Publication type:
- Article
Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention.
- Published in:
- Genes, 2020, v. 11, n. 9, p. 1068, doi. 10.3390/genes11091068
- By:
- Publication type:
- Article